1 / 11

Big Biotech Partnering and M&A Deal Trends (Top 50)

View Complete Report @ http://goo.gl/SYyFVx “Top 50 Big Biotech Partnering and M&A Deal Trends“ report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the world’s leading fifty big biotech companies.

jamesmarsh
Download Presentation

Big Biotech Partnering and M&A Deal Trends (Top 50)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Top 50 Big Biotech Partnering and M&A Deal TrendsByCurrent Partnering Browse more reports on Life Sciences @ http://www.rnrmarketresearch.com/reports/life-sciences. Single User License: US $2495 Corporate User License: US $12475 Published: April 2015 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  2. Top 50 Big Biotech Partnering and M&A Deal Trends The Top 50 Big Biotech Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the world’s leading fifty big biotech companies. Top 50 Big Biotech Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big biotech companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2010 – number of deals per year Full listing of partnering deals Complete report available @ http://www.rnrmarketresearch.com/partnering-deals-and-alliances-with-big-biotech-market-report.html. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  3. Top 50 Big Biotech Partnering and M&A Deal Trends key benefits(Continued): Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeutic area Comprehensive access to over 1,500 partnering deals as recorded at Current Agreement, together with contract documents if available Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents Understand the key deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  4. Top 50 Big Biotech Partnering and M&A Deal Trends The Top 50 Big Biotech Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies. This premier report provides all the information you require to better understand big biotech partnering. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110188. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  5. Top 50 Big Biotech Partnering and M&A Deal Trends Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of each big biotech companies dealmaking trends over the last four years. This report contains over 1,500 links to online copies of actual partnering deals as recorded at Current Agreement, together with contract documents if submitted to the Securities Exchange Commission by big biotech and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of big biotech’s dealmaking and business activities. Inquire for discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=110188. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  6. Top 50 Big Biotech Partnering and M&A Deal Trends Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top 50 leading big biotech companies based on 2013 pharmaceutical revenues and dealmaking activity since 2009. Chapter 3 reviews the top partnering and M&A deals of 2010-2015 according to reported deal size. Chapter 4 provides a summary on best practice on how to submit an opportunity to big biotech, to ensure building of relationships and to obtain a prompt assessment and response from the business development function of the prospective partner. Chapter 5 lists forthcoming partnering events where valuable face to face meetings with big biotech provide a highly effective means of obtaining interest in novel opportunities. These events are where dealmaking gets initiated through numerous back to back meetings. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  7. Top 50 Big Biotech Partnering and M&A Deal Trends The main body of the report is provided in chapter 6. In-depth profiles of every big biotech company provide everything required to assess the suitability of a company as a prospective partner. Each profile includes a company overview, partnering activity according to deal type, phase of development, therapy area and technology type. Each company profile provides a comprehensive listing of deal records available at Current Agreements, each of which links direct to an online copy of the actual deal record plus contract document if filed with the SEC. One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  8. Top 50 Big Biotech Partnering and M&A Deal Trends This data driven report contains over 1,500 links to online copies of actual deal records at Current Agreements and contract documents, where submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. In summary, the report provides the reader with the tools necessary to make successful contact with the right big biotech partners effectively and efficiently. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  9. Top 50 Big Biotech Partnering and M&A Deal Trends • Benefits • Top 50 Big Biotech Partnering and M&A Deal Trends provides the user with the following key benefits: • Detailed partnering activity profiles for each of the top 50 big biotech companies • Over 300 charts showing a company’s dealmaking activity since 2010, allowing quick identification potential partners • Partnering therapy focus revealed • Partnering activity since 2010 – number of deals per year • Full listing of partnering deals • Activity by deal type • Activity by industry sector © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  10. Top 50 Big Biotech Partnering and M&A Deal Trends • Benefits(Continued): • Activity by phase of development • Activity by technology type • Activity by therapeutic area • Comprehensive access to over 1,500 partnering deals, together with contract documents if available • Insight into the terms included in a partnering agreement, together with real world clause examples, via contract documents • Understand the key deal terms the company has agreed in previous deals • Undertake due diligence to assess suitability of your proposed deal terms for partner companies • Inquire before buying this report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=110188. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  11. Top 50 Big Biotech Partnering and M&A Deal Trends For more details contact Mr. RiteshTiwari:sales@rnrmarketresearch.com/ +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnR  Market Research library has syndicated reports by leading market research  publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

More Related